Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06474819 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy

Study acronym: DEEP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 5 to 6
    • Primary and study completion dates: Jan 2, 2027 to Jan 12, 2027
    • Start date changed from estimate of Jul 2, 2024 to Jul 12, 2024
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Multicenter randomized controlled trial which will include patients with left ventricular ejection fraction \>50% requiring a first implant of a cardiac pacemaker with expected high pacing percentages. Patients will be randomized 1:1 to right ventricular apical pacing vs left septal or deep septal pacing. The primary endpoint will be pacing-induced cardiomyopathy during the first year of follow-up.
Trial Details
NCT Number NCT06474819
Lead Sponsor Institut d'Investigació Biomèdica de Bellvitge
Collaborators: Fundació La Marató de TV3, Hospital Universitari de Bellvitge
Conditions
(from sponsor)		 Complete Heart Block, Second Degree Atrioventricular Block Möbitz Type II
Enrollment 326 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov